ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 48 filers reported holding ENTRADA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,401 | +6.6% | 3,000,037 | +2.1% | 0.01% | +16.7% |
| Q2 2023 | $44,487 | +2.8% | 2,938,308 | -1.5% | 0.01% | 0.0% |
| Q1 2023 | $43,267 | +6.2% | 2,983,863 | -1.0% | 0.01% | -14.3% |
| Q4 2022 | $40,754 | -99.9% | 3,014,377 | +1.4% | 0.01% | -12.5% |
| Q3 2022 | $46,840,000 | +57.8% | 2,972,050 | +21.9% | 0.01% | +100.0% |
| Q2 2022 | $29,689,000 | +26.7% | 2,437,498 | -2.3% | 0.00% | +100.0% |
| Q1 2022 | $23,425,000 | -32.3% | 2,494,714 | +23.5% | 0.00% | -33.3% |
| Q4 2021 | $34,593,000 | – | 2,020,637 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,425,784 | $69,750,000 | 26.57% |
| 5AM Venture Management, LLC | 4,408,379 | $69,476,000 | 13.31% |
| 72 Investment Holdings, LLC | 509,023 | $8,022,000 | 6.36% |
| TCG Crossover Management, LLC | 642,189 | $10,121,000 | 3.04% |
| StepStone Group LP | 761,277 | $11,998,000 | 1.71% |
| Nan Fung Group Holdings Ltd | 141,593 | $2,232,000 | 1.42% |
| Redmile Group, LLC | 1,954,419 | $30,802,000 | 1.20% |
| Baker Brothers Advisors | 4,865,819 | $76,685,000 | 0.50% |
| MOORE CAPITAL MANAGEMENT, LP | 105,000 | $1,655,000 | 0.04% |
| Laurion Capital Management LP | 199,066 | $3,137,000 | 0.02% |